Dr. Sneha D. Phadke, DO

Dr. Phadke practices at University of Iowa Health Care Medical Center in Iowa City, Iowa, part of The University of Iowa.

Dr. Phadke's NPI, 1437460482, was assigned on June 24, 2010. Dr. Phadke holds Iowa license DO-04634.

Dr. Phadke's primary practice is University of Iowa Health Care Medical Center, at 200 Hawkins Drive, Iowa City, IA 52242 in Johnson County. The practice phone is (319) 356-1616.

Dr. Phadke's primary practice is University of Iowa Health Care Medical Center in Iowa City, Iowa, part of The University of Iowa. Dr. Phadke is also affiliated with University of Iowa Health Care Medical Center Downtown. The medical group on file is Scanlan Center for School Mental Health Clinic. Dmand AI also links Dr. Phadke to 2 more hospitals, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Phadke practices, 4 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Phadke's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dmand AI has Dr. Phadke's licenses on file in 2 states: Iowa and Kansas.

CMS data shows 533 Medicare services from Dr. Phadke across 5 procedure codes in 2024, for 192 Medicare patients. Medicare paid $29,103 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 192 Medicare patients who saw Dr. Phadke in 2024. The largest group is 65 to 74, with 100 patients. 75% of them have cancer, and 63% have high blood pressure. 7% are also on Medicaid. Their average risk score is 1.44, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Phadke's median patient age at 72, with 97% women.

In 2024, Dr. Phadke wrote 840 Medicare Part D claims for 167 patients. 88% of them were for generic drugs. CMS names the drug for 753 of them, across 11 drugs with 11 or more claims each, at $989,674 in total drug cost. In 2023, CMS named 677 claims across 10 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 80 out of 100 for Dr. Phadke for performance year 2024, reported as part of a group. Dr. Phadke accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Phadke as offering telehealth.

Dmand AI links 19 papers to Dr. Phadke, published from 2015 to 2025. 2022 was the busiest year, with 5. The most frequent topics are Breast Neoplasms, Antineoplastic Combined Chemotherapy Protocols and Antineoplastic Agents. Dr. Phadke has published most often in Clin Breast Cancer. Dr. Phadke's most frequent co-authors are Ingrid M. Lizarraga, MD, Sonia L. Sugg, MD and Jad El Masri, MD.

Dmand AI links Dr. Phadke to 5 clinical trials, 2 of them phase 2 studies. 4 are still active or recruiting. Conditions studied include Breast Neoplasms, Breast Diseases and Hereditary Sensory and Autonomic Neuropathies.

CMS Open Payments shows 2 general payments to Dr. Phadke from 2 drug and device companies from 2016 to 2021. Food and beverage make up the largest share, 85% of the total. Pfizer Inc. paid the most, $65.